These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 29144096)

  • 1. Long-term treatment with etanercept monotherapy in a hemodialyzed patient with moderate-to-severe plaque-type psoriasis and psoriatic arthritis.
    Babino G; Esposito M; Bianchi L; Giunta A
    G Ital Dermatol Venereol; 2018 Dec; 153(6):882-884. PubMed ID: 29144096
    [No Abstract]   [Full Text] [Related]  

  • 2. Etanercept biosimilar SB4 in the treatment of plaque-type psoriasis and psoriatic arthritis: a single-centre, observational, retrospective, real-life study.
    Giunta A; Manfreda V; Esposito M; Del Duca E; Bianchi L
    Br J Dermatol; 2019 Nov; 181(5):1078-1079. PubMed ID: 31049938
    [No Abstract]   [Full Text] [Related]  

  • 3. TNF-α in a molecularly targeted therapy of psoriasis and psoriatic arthritis.
    Wcisło-Dziadecka D; Zbiciak-Nylec M; Brzezińska-Wcisło L; Mazurek U
    Postgrad Med J; 2016 Mar; 92(1085):172-8. PubMed ID: 26719452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of subcutaneous anti-tumor necrosis factor-alpha agents, etanercept and adalimumab, in elderly patients affected by psoriasis and psoriatic arthritis: an observational long-term study.
    Esposito M; Giunta A; Mazzotta A; Zangrilli A; Babino G; Bavetta M; Perricone R; Chimenti S; Chimenti MS
    Dermatology; 2012; 225(4):312-9. PubMed ID: 23295383
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Successful ustekinumab treatment of noninfectious uveitis and concomitant severe psoriatic arthritis and plaque psoriasis.
    Mugheddu C; Atzori L; Del Piano M; Lappi A; Pau M; Murgia S; Zucca I; Rongioletti F
    Dermatol Ther; 2017 Sep; 30(5):. PubMed ID: 28833973
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Spotlight on etanercept in plaque psoriasis and psoriatic arthritis.
    Goldsmith DR; Wagstaff AJ
    BioDrugs; 2005; 19(6):401-3. PubMed ID: 16392892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generalised pustular psoriasis induced by cyclosporin a withdrawal responding to the tumour necrosis factor alpha inhibitor etanercept.
    Kamarashev J; Lor P; Forster A; Heinzerling L; Burg G; Nestle FO
    Dermatology; 2002; 205(2):213-6. PubMed ID: 12218252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tuberculosis Infection Despite Isoniazid Prophylaxis in a Patient With Psoriatic Arthritis Treated With Etanercept.
    Giollo A; Carletto A; Tonetta S; Del Bravo P; Rossini M
    J Clin Rheumatol; 2019 Aug; 25(5):e74-e75. PubMed ID: 29280825
    [No Abstract]   [Full Text] [Related]  

  • 9. Angiogenesis in psoriatic skin and its modifications after administration of etanercept: videocapillaroscopic, histological and immunohistochemical evaluation.
    Campanati A; Goteri G; Simonetti O; Ganzetti G; Giuliodori K; Giuliano A; Sabato S; Stramazzotti D; Gulini E; Dusi D; De Blasio S; Fabris G; Offidani A
    Int J Immunopathol Pharmacol; 2009; 22(2):371-7. PubMed ID: 19505391
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab for severe psoriasis and psoriatic arthritis: an open-label study in 30 patients previously treated with other biologics.
    Papoutsaki M; Chimenti MS; Costanzo A; Talamonti M; Zangrilli A; Giunta A; Bianchi L; Chimenti S
    J Am Acad Dermatol; 2007 Aug; 57(2):269-75. PubMed ID: 17574299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Etanercept in the treatment of psoriatic arthritis.
    Puig L; López-Ferrer A; Laiz A
    Actas Dermosifiliogr; 2015 May; 106(4):252-9. PubMed ID: 25455504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The treatment of psoriasis and psoriatic arthritis with etanercept: practical considerations on monotherapy, combination therapy, and safety.
    Yamauchi PS; Gindi V; Lowe NJ
    Dermatol Clin; 2004 Oct; 22(4):449-59, ix. PubMed ID: 15450340
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secukinumab long-term safety experience: A pooled analysis of 10 phase II and III clinical studies in patients with moderate to severe plaque psoriasis.
    van de Kerkhof PC; Griffiths CE; Reich K; Leonardi CL; Blauvelt A; Tsai TF; Gong Y; Huang J; Papavassilis C; Fox T
    J Am Acad Dermatol; 2016 Jul; 75(1):83-98.e4. PubMed ID: 27180926
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of etanercept in psoriasis after switching from other treatments: an observational study.
    Mazzotta A; Esposito M; Costanzo A; Chimenti S
    Am J Clin Dermatol; 2009; 10(5):319-24. PubMed ID: 19658444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Infliximab monotherapy in Japanese patients with moderate-to-severe plaque psoriasis and psoriatic arthritis. A randomized, double-blind, placebo-controlled multicenter trial.
    Torii H; Nakagawa H;
    J Dermatol Sci; 2010 Jul; 59(1):40-9. PubMed ID: 20547039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A case of tuberculosis in a patient on Efalizumab and Etanercept for treatment of refractory palmopustular psoriasis and psoriatic arthritis.
    Kitamura G; Mehr N; Anderson N; Sirichotiratana M
    Dermatol Online J; 2009 Feb; 15(2):11. PubMed ID: 19336028
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Etanercept for the treatment of psoriasis and psoriatic arthritis.
    Gottlieb AB
    Dermatol Ther; 2004; 17(5):401-8. PubMed ID: 15379775
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Psoriasis and psoriatic rheumatism: effectiveness of etanercept for cutaneous and joint lesions].
    Paul C; Solignac M
    Ann Dermatol Venereol; 2010 Apr; 137(4 Suppl):13-5. PubMed ID: 20510165
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of etanercept on C-reactive protein levels in psoriasis and psoriatic arthritis.
    Strober B; Teller C; Yamauchi P; Miller JL; Hooper M; Yang YC; Dann F
    Br J Dermatol; 2008 Aug; 159(2):322-30. PubMed ID: 18503600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics and systemic therapies administered to first-time patients at a tertiary psoriasis outpatient clinic.
    Bonifati C; Graceffa D; Lora V; Maiani E
    G Ital Dermatol Venereol; 2016 Dec; 151(6):596-602. PubMed ID: 26505567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.